Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the IUPAC name (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide) . It belongs to the class of organic compounds known as N-acyl-alpha amino acids and derivatives. The molecule has not been approved for any therapeutic use and is classified as experimental. There are no reported clinical trials or approved indications for this compound. Its mechanism of action and biological targets are not described in available databases[1][2][7]. Some sources list it under synonyms such as (E)-(…nonenoic acid ((…azepan…yl) amide), TDE and (R)-retrothiorphan[1][7]. No information on pharmacological activity or disease relevance is available.
- Other names
- (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-((3S,6R)-6-hydroxy-2-oxo-3-azepanyl)-2-methoxy-8,8-dimethyl-6-nonenamide(2R,3R,4S,5R,6E)-3,4,5-trihydroxy-N-( ( 3 S , 6 R ) - 6 - hydroxy - 2 - oxoazepan - 3 - yl ) - 2 - methoxy - 8 , 8 dimethylnon – 6 – enamide(E)-(2R , 3 R , 4 S , 5 R ) – – TRIHYDROXY – – METHOXY – – DIMETHYL NON – ENOIC ACID (( – HYDROXY – OXO AZEPAN – YL) AMIDE(R)-RETROTHIORPHANTDE
Beyond the preview
Go deeper on (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2R,3R,4S,5R,6E)-3,4,5-Trihydroxy-N-[(3S,6R)-6-hydroxy-2-oxo-3-azepanyl]-2-methoxy-8,8-dimethyl-6-nonenamide.